NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

You’re right CherryTree1, even those patients who are not “effectively cured”, all or most GBM patients should & will benefit from DCVax-L.

As Dr. Linda Liau stated, “all patients are living longer”, and as Dr. Ashkan Keyoumars stated: “l want this available for all my GBM patients”.

There is a lot to be said for significantly extending overall survival (OS) across the board for all GBM patients. The current GBM SOC (the Stupp Protocol) was approved for all GBM patients, even though it only added about 2.5 months of OS for GBM patients. DCVax-L should be, and in my opinion will be, approved for all ndGBM & rGBM patients.